Autolus Therapeutics (AUTL) Treasury Shares (2017 - 2025)

Autolus Therapeutics (AUTL) has reported Treasury Shares for 9 consecutive years, with $92500.0 the latest figure, recorded in Q4 2025.

• Quarterly Treasury Shares rose 185.39% year-over-year to $92500.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $92500.0 (up 185.39% YoY) and the FY2025 annual result came in at $92500.0, up 185.39% from the prior year.
• Treasury Shares retreated to $92500.0 in Q4 2025 per AUTL's latest filing, from $94375.0 in the prior quarter.
• Over the last five years, Treasury Shares for AUTL reached as high as $1.3 million in Q1 2021 and fell as low as $16250.0 in Q1 2025.
• A 5-year average of $392526.0 and a median of $93437.5 in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2024 — Treasury Shares sank 72.16% — and 2025, when it soared 185.39%.
• Year by year, Treasury Shares stood at $1.1 million in 2021, then slumped by 62.99% to $403331.0 in 2022, then sank by 71.13% to $116436.0 in 2023, then plunged by 72.16% to $32412.0 in 2024, then surged by 185.39% to $92500.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $92500.0, $94375.0, and $16250.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.